Chemotherapy for stage IV (metastatic) cancer
Saltz LB et al. Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) verus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer. 2005 ASCO annual meeting. Abstract 3508